Status:
RECRUITING
Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury
Lead Sponsor:
BayCare Health System
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Brief Summary
To determine the clinical utility of serum cystatin C in early detection of acute kidney injury (AKI).
Detailed Description
The primary objective of this study is to evaluate the clinical utility of Cystatin C in early detection of contrast-induced AKI. To evaluate the effect of patient characteristics in the Cystatin C b...
Eligibility Criteria
Inclusion
- Subjects ages 18 years and above
- Inpatients with CKD (Figure 1)
- Order for CT imaging study or coronary angiography with isohexol Omnipaque) contrast media.
- Pre and post contrast available
- All races and ethnicity of patients are eligible. We expect to analyze approximately equal number of men and women in this study.
Exclusion
- Preexisting dialysis
- Patients under the age of 18 years
- Pregnancy
- Incarcerated individuals
- Patients with impaired cognition and unable to follow consent procedures
- Recent exposure to CM (within 2 days before/after procedure)
- Cardiac shock
- Medications that affect biomarkers, including corticosteroids, lfamethoxazoletrimethoprim
Key Trial Info
Start Date :
March 11 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07197957
Start Date
March 11 2025
End Date
February 28 2027
Last Update
September 30 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Morton Plant Hospital
Clearwater, Florida, United States, 33756
2
Morton Plant North Bay Hospital
New Port Richey, Florida, United States, 34652
3
Mease Countryside Hospital
Safety Harbor, Florida, United States, 34695
4
St. Anthony's Hospital
St. Petersburg, Florida, United States, 33705